Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI | Zendy

Hirotoshi Watanabe | Zendy; Takenori Domei | Zendy; Takeshi Morimoto | Zendy; Masahiro Natsuaki | Zendy; Hiroki Shiomi | Zendy; Toshiaki Toyota | Zendy; Masanobu Ohya | Zendy; Satoru Suwa | Zendy; Kensuke Takagi | Zendy; Mamoru Nanasato | Zendy; Yoshiki Hata | Zendy; Masahiro Yagi | Zendy; Nobuhiro Suematsu | Zendy; Takafumi Yokomatsu | Zendy; Itaru Takamisawa | Zendy; Masayuki Doi | Zendy; Toshiyuki Noda | Zendy; Hideki Okayama | Zendy; Yoshitane Seino | Zendy; Tomohisa Tada | Zendy; Hiroki Sakamoto | Zendy; Kiyoshi Hibi | Zendy; Mitsuru Abe | Zendy; Kazuya Kawai | Zendy; Kōichi Nakao | Zendy; Kenji Andò | Zendy; Kengo Tanabe | Zendy; Yuji Ikari | Zendy; Keiichi Igarashi Hanaoka | Zendy; Yoshihiro Morino | Zendy; Ken Kozuma | Zendy; Kazushige Kadota | Zendy; Yutaka Furukawa | Zendy; Yoshihisa Nakagawa | Zendy; Takeshi Kimura | Zendy

Open Access

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

Author(s) -

Hirotoshi Watanabe,

Takenori Domei,

Takeshi Morimoto,

Masahiro Natsuaki,

Hiroki Shiomi,

Toshiaki Toyota,

Masanobu Ohya,

Satoru Suwa,

Kensuke Takagi,

Mamoru Nanasato,

Yoshiki Hata,

Masahiro Yagi,

Nobuhiro Suematsu,

Takafumi Yokomatsu,

Itaru Takamisawa,

Masayuki Doi,

Toshiyuki Noda,

Hideki Okayama,

Yoshitane Seino,

Tomohisa Tada,

Hiroki Sakamoto,

Kiyoshi Hibi,

Mitsuru Abe,

Kazuya Kawai,

Kōichi Nakao,

Kenji Andò,

Kengo Tanabe,

Yuji Ikari,

Keiichi Igarashi Hanaoka,

Yoshihiro Morino,

Ken Kozuma,

Kazushige Kadota,

Yutaka Furukawa,

Yoshihisa Nakagawa,

Takeshi Kimura

Publication year - 2019

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2019.8145

Subject(s) - medicine , clopidogrel , conventional pci , percutaneous coronary intervention , clinical endpoint , aspirin , randomized controlled trial , stroke (engine) , myocardial infarction , cardiology , stent , surgery , mechanical engineering , engineering

Very short mandatory dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with a drug-eluting stent may be an attractive option.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research